Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-27.9M $-29.5M $46.0K $-35.7M $-38.4M $-68.9M $-96.9M $-111.4M
Depreciation & Amortization — — — — — — — —
Depreciation $76.0K $81.0K $56.0K $47.0K $320.0K $830.0K $1.6M $1.6M
Amortization — — — — — — — —
Stock-Based Compensation $8.1M $8.2M $8.4M $7.7M $4.4M $5.3M $15.2M $13.7M
Net Cash from Operating Activities $-20.6M $-18.4M $-24.2M $9.4M $-36.7M $-55.1M $-62.4M $-44.3M
Investing Activities
Capital Expenditures — $57.0K $90.0K $131.0K $3.0K $862.0K $612.0K $836.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $23.0M $8.8M $73.0K — — — $32.1M $-48.5M
Financing Activities
Dividends Paid — — $0 $0 $0 — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $1.1M $1.2M $2.6M — — — $386.0K $104.1M
Net Change in Cash $3.5M $-8.4M $-21.5M — — — $-29.9M $11.4M
Free Cash Flow — $-18.4M $-24.3M $9.2M $-36.7M $-56.0M $-63.0M $-45.1M
← Newer Page 2 of 3 Older →